Alcohol Policies, Ozempic Dental Health, and Germany's PubMed Alternative

In this episode, Dr. Chi-Ming Chow opens with an introduction to the day's topics, focusing first on recent changes in alcohol sales policies and providing an update on the latest COVID-19 variants. The discussion then shifts to dental health concerns associated with the use of Ozempic, an increasingly popular medication. Dr. Chow examines the issue of physician appointment wait times in the United States, highlighting the challenges faced by patients seeking timely care. The episode also covers Germany's proposal for a global alternative to PubMed, exploring its potential impact on medical research accessibility. The episode concludes with a wrap-up of the key discussions.